Non-invasive Prenatal Testing Market (Product - Consumables, and Instruments; Method - Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, and Fetal Cells in Maternal Blood Tests; Application - Trisomy, Microdeletion Syndrome, and Other Applications; End User - Diagnostic Laboratories, and Hospitals): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : July, 2019

  • Rep Id : HC0621

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the non-invasive prenatal testing market provides an in-depth analysis of segments and sub-segments in the global as well as regional non-invasive prenatal testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional non-invasive prenatal testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global non-invasive prenatal testing market. According to the report, the global non-invasive prenatal testing market is projected to grow at a CAGR of 17.2% over the forecast period of 2019-2025.

 

Market Insight

Rising frequency of diseases and innovation of new medical treatments are the major factors for the growth of the non-invasive prenatal testing market. According to the World Health Organization, the total healthcare expenses are increasing across the globe, which is leading to an improvement in the healthcare infrastructure. Also, growing maternal age and rising demand for early and non-invasive fetal testing procedures are the other factors for the growth of the global market. The rise in healthcare expenditure leads to an increase in affordability and accessibility of the new test and treatment for various conditions that in turn is helping in the growth of the non-invasive prenatal testing market. The increased shift from invasive methods to non-invasive methods and growth of maternal age also boosts the growth of the market. However, the lack of skilled experts, as well as strict regulatory guidelines, are some of the factors that may hinder the growth of the market. Besides, the increasing amount of collaborations and partnerships creates an opportunity for the growth of the non-invasive prenatal testing market in the upcoming years.

 

In terms of region, the global non-invasive prenatal testing market is categorized into North America, Europe, Asia-Pacific and the Rest of the World. Among all, North America is leading the global non- invasive prenatal testing and is expected to dominate the global market over the forecast period. This is attributed to high government spending for research and development activities and the presence of established healthcare research in the region. On the other hand, Asia-Pacific is projected to grow at a rapid speed over the forecast period. This is credited to the rising average maternal age, development in healthcare facilities and high frequency of chromosomal abnormalities in the region. Additionally, rising exposure for clinical research in India and Australia are also estimated to support the growth of the global non-invasive prenatal market in the Asia-Pacific in the next few years. Furthermore, advancing maternal age and high-risk pregnancies in China are expected to create beneficial growth opportunities for the regional market in the upcoming years.

 

Segment Covered

The report on the global non-invasive prenatal testing market covers segments such as product, method, application, and end user. On the basis of product, the sub-markets include consumables, and instruments. On the basis of method, the sub-markets include ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, and fetal cells in maternal blood tests. On the basis of application, the sub-markets include trisomy, microdeletion syndrome, and other applications. On the basis of end user, the sub-markets include diagnostic laboratories, and hospitals.

 

Companies Profiled:

The report provides profiles of the companies in the market such as BGI Group, Berry Genetics, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc., Hoffmann-La Roche Ltd., NATERA, INC., PerkinElmer Inc., Eurofins LifeCodexx AG, and IGENOMIX.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of non-invasive prenatal testing market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount